Intezyne Technologies, Inc.
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
10
Ending by 2030
Jul 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 25, 2026The maintenance fee for Melanocortin 1 Receptor Ligands and Methods of Use (US 10,329,326) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
- 2 fees due Jan 14 to 28, 2027 · next Jan 14
- 1 fee due Sep 15, 2027The maintenance fee for Medicaments and methods for treating cancer (US 9,283,208) comes due Sep 15, 2027. Unpaid by Mar 15, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,263,665 | Polymeric micelles for drug delivery In force · From the USPTO record | In force | From the USPTO record | |
| US 7,601,796 | Synthesis of hybrid block copolymers and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 7,893,277 | Poly(ethylene glycol) containing chemically disparate endgroups In force · From the USPTO record | In force | From the USPTO record | |
| US 8,207,353 | Poly(ethylene glycol) containing chemically disparate endgroups In force · From the USPTO record | In force | From the USPTO record | |
| US 7,638,558 | Polymeric micelles for drug delivery In force · From the USPTO record | In force | From the USPTO record | |
| US 8,980,326 | Hybrid Block Copolymer Micelles with Mixed Stereochemistry for Encapsulation of Hydrophobic Agents In force · Low confidence | In force | Low confidence | |
| US 7,799,339 | Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents In force · From the USPTO record | In force | From the USPTO record | |
| US 8,066,824 | Covalent modification of metal surfaces In force · From the USPTO record | In force | From the USPTO record | |
| US 8,212,083 | Heterobifunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,629,186 | Polymer micelles containing anthracyclines for the treatment of cancer In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 25: 6 patents in force now held by others · 11 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 3 abandoned · 25 no status recorded